ArticlePDF Available

Black tea consumption improves postprandial glycemic control in normal and pre-diabetic subjects: A randomized, double-blind, placebo-controlled crossover study

Authors:

Abstract and Figures

Background and objectives: Postprandial glycemic control is important for prevention of diabetes. Black tea consumption may improve postprandial glycemic control. The major bioactive compounds are polyphenols, black tea polymerized polyphenol (BTPP).This study examined the effect of black tea consumption on postprandial blood glucose and insulin response following sucrose loading in normal and pre-diabetes subjects. Methods and study design: This study was a randomized, double-blind, placebo-controlled crossover study. Twenty-four subjects, male and female aged 20-60 years, normal and pre-diabetic, randomly ingested a sucrose solution with a low dose (110 mg BTPP), a high dose (220 mg BTPP) of black tea drink or a placebo drink (0 mg BTPP). Blood samples were collected at 0, 30, 60, 90, and 120 min from commencement of drink ingestion to measure blood glucose and insulin levels. Results: The drink containing low dose and high dose BTPP significantly decreased incremental blood glucose area under the curve (AUC) after sucrose intake compared with placebo in the normal (T0-60 min 3,232±356 vs 3,295±312 vs 3,652±454 mg.min/dL; p=0.016) and pre-diabetic subjects (T0-60 min 2,554±395 vs 2,472±280 vs 2,888±502 mg.min/dL; p=0.048). There was no statistically significant difference of changes in insulin levels between the placebo and black tea groups (p>0.05). No significant differences in adverse effects were observed with the placebo, low dose and high dose of BTPP groups. Conclusion: Black tea consumption can decrease postprandial blood glucose after sucrose intake.
Content may be subject to copyright.
Asia Pac J Clin Nutr 2017;26(1):59-64 59
Original Article
Black tea consumption improves postprandial glycemic
control in normal and pre-diabetic subjects:
a randomized, double-blind, placebo-controlled
crossover study
Arisa Butacnum MSc, Rewadee Chongsuwat PhD, Akkarach Bumrungpert PhD
Department of Nutrition, Faculty of Public Health, Mahidol University, Bangkok, Thailand
Background and Objectives: Postprandial glycemic control is important for prevention of diabetes. Black tea
consumption may improve postprandial glycemic control. The major bioactive compounds are polyphenols, black
tea polymerized polyphenol (BTPP).This study examined the effect of black tea consumption on postprandial
blood glucose and insulin response following sucrose loading in normal and pre-diabetes subjects. Methods and
Study Design: This study was a randomized, double-blind, placebo-controlled crossover study. Twenty-four sub-
jects, male and female aged 20-60 years, normal and pre-diabetic, randomly ingested a sucrose solution with a
low dose (110 mg BTPP), a high dose (220 mg BTPP) of black tea drink or a placebo drink (0 mg BTPP). Blood
samples were collected at 0, 30, 60, 90, and 120 min from commencement of drink ingestion to measure blood
glucose and insulin levels. Results: The drink containing low dose and high dose BTPP significantly decreased
incremental blood glucose area under the curve (AUC) after sucrose intake compared with placebo in the normal
(T0-60 min 3,232±356 vs 3,295±312 vs 3,652±454 mg.min/dL; p=0.016) and pre-diabetic subjects (T0-60 min
2,554±395 vs 2,472±280 vs 2,888±502 mg.min/dL; p=0.048). There was no statistically significant difference of
changes in insulin levels between the placebo and black tea groups (p>0.05). No significant differences in adverse
effects were observed with the placebo, low dose and high dose of BTPP groups. Conclusion: Black tea con-
sumption can decrease postprandial blood glucose after sucrose intake.
Key Words: glycemic control, diabetes, black tea, black tea polymerized polyphenols, catechins
INTRODUCTION
Current epidemiology has estimated that the prevalence
of diabetes is increasing rapidly with significant medical
and economic consequences.1 The global prevalence of
diabetes was 171 million people in the year 2000, and it is
projected to increase to 366 million by 2030. The disease
is accompanied by high costs mainly due to chronic com-
plications. Diabetes and its complications have many
negative effects for health. Cardiovascular disease (CVD)
is the most common.
Postprandial glycemic control is important for preven-
tion of diabetes and/or delay of its complications. Moreo-
ver, the postprandial hyperglycemia in diabetic patients is
a more powerful marker of cardiovascular disease risk
than fasting hyperglycemia.2 Several experimental studies
provide a plausible pathophysiological explanation for
epidemiological data and give strength to the idea that
postprandial hyperglycemia is harmful.
The easiest way to prevent hyperglycemia is to control
blood glucose level in the normal range. Management
concentrates on keeping blood sugar levels as close to
normal as possible, without causing hypoglycemia. This
can usually be accomplished with diet, exercise, and use
of appropriate medications. Nevertheless prevention and
treatment of diabetes are not only available with conven-
tional medicine but also with alternative medicine. Func-
tional foods and nutritional supplements are promising
alternative medicines which have been used for regulation
of plasma glucose to prevent diabetes in order to save
costs for treatment of diabetes and complications.
Black tea is produced from the fresh leaves of Camellia
sinensis. It is one of the most widely consumed beverages
in the world. During the oxidation process, polyphenols
present in the tea leaf, the catechins, are enzymatically
converted to numerous polymerized polyphenols includ-
ing theaflavins and thearubigens.3 The major bioactive
compounds of black tea areblack tea polymerized poly-
phenol (BTPP).4 The health benefits of black tea poly-
phenols include anti-oxidant,4-6 anti-inflammatory,6-8 anti-
cancer,9,10 and anti-h ypertensive effects.11, 12 Moreover,
invitro studies suggest that extracts of black tea could
Corresponding Author: Dr Akkarach Bumrungpert, Depart-
ment of Nutrition, Faculty of Public Health, Mahidol Universi-
ty, 420/1 Rajvithi Road, Ratchathewi District, Bangkok 10400,
Thailand.
Tel: (+66) 2644-6842 Ext. 1205, (+66) 2354-8539
Email: abnutrition@yahoo.com; akkarach.bum@mahidol.ac.th
Manuscript received 03 September 2015. Initial review com-
pleted 13 September 2015. Revision accepted 18 October 2015.
doi: 10.6133/apjcn.112015.08
60 A Butacnum, R Chongsuwat and A Bumrungpert
interfere with carbohydrate absorption via their ability to
inhibit α-amylase, α-glucosidase, and sodium-glucose
transporters.13-16 Also, an animal study has shown the
suppressive effect of black tea polymerized polyphenol
on postprandial blood glucose in mice (unpublished).
Zhong et al found that the black tea extract induced mal-
absorption of 25% of the carbohydrate in healthy adult
human volunteers.17 Furthermore, Bryans et al established
that black tea decreases plasma glucose response in
healthy humans with a corresponding increase in insulin
level.18 However, there has been little clinical research on
the effects of black tea on postprandial glycemic control
and the results are not clear, especially in humans. There-
fore, our primary objective was to study the effect of
black tea consumption on postprandial blood glucose af-
ter sucrose loading in normal and pre-diabetic subjects.
MATERIALS and METHODS
The study was approved by the Ethical Review Commit-
tee for Human Research, Faculty of Public Health, Mahi-
dol University (MUPH 2014-145). Furthermore, this
study was conducted in accordance with the Declaration
of Helsinki on human subjects.
Subjects
We conducted a study in subjects with different back-
grounds by selecting normal subjects and pre-diabetic
subjects in order to ascertain the suppressive effect of the
black tea on sugar absorption. Twenty-four subjects aged
20-60 years were recruited at the Department of Nutrition,
Faculty of Public Health, Mahidol University. The inclu-
sion criterion for the normal group was fasting blood glu-
cose level of 70 to 100 mg/dL, pre-diabetic group was
fasting blood glucose level of 100-125 mg/dL. Subjects
had no diabetes, kidney or liver disease. Subjects who
were smokers, pregnant or nursing, regular users of a
pharmaceutical or food supplement that impacts glucose
metabolism were excluded. Also subjects were excluded
if they drank more than three cups daily of tea. Subjects
voluntarily participated in the study and provided written
informed consent.
Study materials
Menu set
The dinner for the day before the test day was prepared
by research assistants. The dinner consisted of rice,
minced fish dip with vegetables and rib soup, with energy
distribution carbohydrate 57%, protein 13%, and fat 30%.
Beverages
The test drink and placebo drink were manufactured by
Suntory Beverage & Food Limited (Japan). The composi-
tion of the test drinks and placebo drink are shown in Ta-
ble 1. Black tea drink was produced by extraction of
black tea leaves by hot water, and removing caffeine and
catechins. There were 2 doses of black tea drinks, low
dose (110 g BTPP) and high dose (220 g BTPP). Placebo
drink contained water and caramel coloring. The test
drink and placebo drink were packaged in cans.
Study design
This study design was a randomized, double-blind, place-
bo-controlled, crossover trial. The study consisted of one
baseline visit on the screening day and three visits on the
test day. Twenty-four subjects were selected from 72
candidates by a screening test and physical examination.
Blood pressure was measured by nurse after at least 5 min
of seated rest in a chair. Subjects were allocated to differ-
ent groups by the allocation manager based on their sex
and fasting glucose values. A total of 24 subjects were
randomly assigned into 2 major groups, normal and pre-
diabetic. There were 13 normal subjects (7 men and 6
women) and 11 pre-diabetic subjects (5 men and 6 wom-
en). Then subjects were randomly divided again to 3 mi-
nor groups for each test drink: a drink containing low
dose (110 g BTPP), a drink containing high dose (220 g
BTPP) and a placebo drink (0 g BTPP). Subjects con-
sumed the test drink with a 50 g sucrose solution (200
mL) prepared separately on each study day.
On the day before the study day, subjects abstained
from excessive eating and consumed the dinner specified
by the researcher. The specified dinner was picked up by
the subjects themselves from the Department of Nutrition,
Faculty of Public Health, Mahidol University. Alcohol
consumption was prohibited on the day before the study,
and the consumption of all foods and drinks except water
was also prohibited after 9 pm. Physical exercise was also
prohibited. Subjects reported to the study institution in a
fasting state. Then, a blood sample was collected from the
subjects at 0 min before sucrose loading. After that, the
beverage given to the treatment group was black tea drink
(500 mL) containing 110 mg of BTPP or 220 mg of
BTPP while the control group was given a placebo drink.
Then, each subject from the 3 groups was asked to ingest
50 grams of sucrose solution (200 mL) within 5 min.
Subsequently, subjects rested in the examination room
and blood was collected at 30, 60, 90, and 120 minutes
after sucrose loading (blood sample volume, 3 mL each).
Table 1. The composition of the test drinks and placebo drink
Nutritional content Test drinks (500 mL) Placebo drink (500 mL)
Low dose BTPP High dose BTPP
Energy (kcal) 0 0 0
Carbohydrates (g) ND ND ND
Fat (g) ND ND ND
Protein (g) ND ND ND
Sodium (mg) ND ND ND
Caffeine (mg) 0 0 0
BTPP (mg) 110 220 0
ND: Not detectable (<0.1 g/100 mL).
Black tea improves postprandial glycemic control 61
The plasma was separated from the samples and used to
measure blood glucose and insulin levels.
After the experiment, all subjects were asked to keep a
diary of severity of abdominal and other symptoms to
monitor the effect of the beverages they received. All
subjects were tested with the other groups as cross-over
study. Each participant received all treatments on the
same day of the week and had a 1 week washout period
between treatments: low dose BTPP, high dose BTPP and
placebo drink. This included result measurements and
monitoring of adverse events.
Analyses of blood samples
The following parameters were measured for screening
test and general characteristic of subjects: serum total
cholesterol (TC), low-density lipoprotein cholesterol
(LDL-C), high-density lipoprotein cholesterol (HDL-C),
triglycerides (TG), fasting blood glucose (FBG), HbA1C,
insulin, hemoglobin (Hb), hematocrit (Hct), serum glu-
tamic oxaloacetic transaminase (SGOT), serum glutamic
pyruvic transaminase (SGPT), alkaline phosphatase
(ALP), gamma-glutamyl transpeptidase (-GTP), uric
acid, blood urea nitrogen (BUN), creatinine, bilirubin,
lactate dehydrogenase, and creatine kinase. All bi-
omarkers were measured at N-Health Asia Lab, Thailand,
a medical laboratory with ISO15189:2007 certification.
Statistical analysis
The data were presented as mean±SD. Statistical differ-
ences of the means of incremental blood glucose AUC
and incremental blood insulin between the treatment and
the placebo groups were tested by one-way ANOVA and
post-hoc (Tukey) analysis. The adverse symptoms were
compared between ingestion of black tea and placebo
using one-way ANOVA. The levels of significance were
set to p<0.05.
RESULTS
Characteristics of subjects at baseline
Twenty four volunteers (13 normal subjects; 7 men, 6
women and 11 pre-diabetic subjects; 5 men, 6 women)
were recruited for the study. The mean ages of normal
and pre-diabetic subjects were 33.9 and 44.6 years, the
average BMI were 25.0 and 28.7 kg/m2, and mean glu-
cose levels were 89.9 and 108 mg/dL, respectively. Other
biochemical markers are shown in Table 2. All the sub-
jects were able to follow the study protocol and finish the
study.
Postprandial glucose and insulin response
The effect of the black tea on blood glucose and insu-
lin levels after sucrose loading in normal subjects
The postprandial responses in the blood glucose levels
following the ingestion of sucrose with the black tea drink
containing BTPP (low dose) significantly decreased in-
cremental blood glucose area under the curve (AUC) after
sucrose intake at 60, 90 and 120 mins compared with pla-
cebo (Figure 1A). Likewise, the BTPP (high dose) signif-
icantly suppressed the postprandial elevation in incremen-
tal blood glucose area under the curve (AUC) at 90 and
120 mins compared with placebo (Figure 1A). Moreover,
the incremental blood glucose after the intake of sucrose
with the black tea drink containing BTPP (low dose) was
significantly decreased at 60 min (91.4±8.19 vs 101±13.3
mg/dL) and 120 min (3.15±4.30 vs 9.46±3.93 mg/dL)
compared with placebo. Also, the incremental blood glu-
Table 2. General characteristic and blood chemistry of subjects
General characteristic and biochemical parameters Normal Pre-diabetic
Total number, men/women (n) 13 (7/6) 11 (5/6)
Age (years) 33.9±9.24 44.6±10.3
BMI (kg/m
2
) 25.0±3.72 28.7±5.56
Body fat (%) 27.8±7.59 33.9±7.85
Waist circumference (cm) 83.8±8.65 94.1±10.2
Systolic blood pressure (mm Hg) 125±8.77 1230±10.3
Diastolic blood pressure (mm Hg) 78.5±7.24 80.6±3.75
Pulse rate (beat/min) 76.7±8.23 75.9±6.95
Total cholesterol (mg/dL) 216±39.9 244±52.9
LDL-C (mg/dL) 154±32.7 151±30.9
HDL-C (mg/dL) 52.9±9.94 60.6±16.4
Triglyceride (mg/dL) 114±43.0 153±68.4
FBG (mg/dL) 89.9±3.36 108±6.48
HbA1C (%) 5.36±0.18 5.88±0.38
Insulin (
IU/mL) 5.36±3.92 10.2±4.30
Hb (g/dL) 14.3±1.54 13.7±1.73
Hct (%) 43.1±4.22 42.2±3.74
SGOT (U/L) 19.9±7.16 18.8±6.63
SGPT (U/L) 24.2±12.9 22.1±13.0
ALP (U/L) 61.4±14.3 64.8±9.34
-GTP (U/L) 32.4±31.4 48.9±33.1
Uric acid (mg/dL) 4.88±1.15 6.07±1.69
BUN (mg/dL) 10.3±2.23 11.3±2.81
Creatinine (mg/dL) 0.75±0.14 0.79±0.13
Bilirubin (mg/dL) 0.44±0.10 0.48±0.12
Lactate dehydrogenase (U/L) 162±17.5 172±32.53
Creatine kinase (U/L) 112±35.4 110±55.1
62 A Butacnum, R Chongsuwat and A Bumrungpert
cose after the intake of sucrose with the black tea drink
containing BTPP (high dose) was significantly decreased
at 60 min (90.3±9.94 vs 101±13.3 mg/dL) and 120 min
(2.46±3.07 vs 9.46±3.93 mg/dL) compared with placebo.
These results indicated that the black tea drink containing
BTPP could decrease postprandial blood glucose after
sucrose intake in normal subjects. There were no signifi-
cant differences between low dose and high dose of BTPP.
The postprandial responses in the blood insulin levels
following the ingestion of sucrose with or without black
tea drink containing the BTPP (low dose and high dose)
in normal subjects was not statistically significant differ-
ent between placebo, low dose and high dose of BTPP
groups (Figure 2A).
The effect of the black tea on blood glucose and insu-
lin levels after sucrose loading in pre-diabetic subjects
The postprandial responses in the blood glucose levels
following the ingestion of sucrose with the black tea drink
containing BTPP (low dose and high dose) significantly
decreased incremental blood glucose area under the curve
(AUC) after sucrose intake at 60 and 90 min compared
with placebo (Figure 1B). These results indicated that the
black tea drink containing BTPP could decrease post-
prandial blood glucose after sucrose intake in pre-diabetic
subjects. There was no significant difference in effect
between low dose and high dose of BTPP.
The postprandial responses in the blood insulin levels
following the ingestion of sucrose with or without black
tea drink containing the BTPP (low dose and high dose)
in pre-diabetic subjects were not statistically significantly
different between placebo, low dose and high dose of
BTPP groups (Figure 2B).
Adverse effects
Adverse events were assessed for any symptom in the
placebo, low dose and high dose of BTPP groups. They
were rare and no significant differences between the
groups.
DISCUSSION
In this study, we determined the extent to which BTPP
decreased the postprandial elevation in blood glucose
after sucrose intake in normal and pre-diabetic subjects.
We demonstrated that black tea reduced the incremental
blood glucose after sucrose consumption. This is con-
sistent with a previous study which showed that black tea
decreased the plasma glucose r esponse in healthy hu-
mans.17
A possible mechanism of action by which BTPP sup-
(A)
(B)
Figure 1. Effect of the black tea consumption on blood glucose levels after sucrose loading in normal and pre-diabetic subjects. (A)
Incremental b lood glucose AUC after sucrose loading in normal subjects. (B) Incremental blood glucose AUC after sucrose loading in
pre-diabetic subjects. a-b Values with different superscripts are significantly different from each other (p<0.05).
Black tea improves postprandial glycemic control 63
presses elevation of postprandial blood glucose after su-
crose intake is blocking carbohydrate absorption.16 In
vitro studies found that extracts of black tea interfere with
carbohydrate absorption via their abilities to inhibit α-
amylase,12,13 α-glucosidase14 and sodium glucose trans-
porter15 The abilities are similar to those found by Adi-
sakwattana et al19 who demonstrated that cinnamon bark
extracts may be potentially useful for the control of post-
prandial glucose in patients with diabetes through the
ability to inhibit of intestinal α-glucosidase and pancreatic
α-amylase. Likewise, Beejmohun et al20 demonstrated
that cinnamon extract significantly reduced the glycemic
response also in in vitro and in vivo studies by inhibiting
α-amylase activity. They found that 1 g of cinnamon ex-
tract reduced the AUC of glycemia at 0-60 mins (p<0.05)
compared with placebo, but cinnamon extract has no ef-
fect on insulin level. This efficacy of cinnamon for reduc-
tion of postprandial hyperglycemia but not change in in-
sulin level showed the same result as the consumption of
black tea in this study.
Moreover, the result of black tea consumption in this
study is similar to that of Zhong et al.17 They found the
mechanism of black tea extract is its ability to cause car-
bohydrate malabsorption. The conclusion from their study
was that the consumption of black tea extract induced
malabsorption of carbohydrate absorption by 25%.
Based on these findings it is suggested that black tea
inhibited carbohydrate absorption. On the other hand, the
effect of black tea on insulin sensitivity is still inconclu-
sive, since in this study there was no significant differ-
ence in the effects of black tea on insulin sensitivity.
However, the study of Bryans et al18 found black tea re-
duced the late phase plasma glucose response in healthy
humans with a corresponding increase in insulin.
Furthermore, the adverse events and the severity of
symptoms reported by the subjects for the 8 hrs of study
showed no significant differences in symptoms for the
placebo, low dose and high dose of BTPP groups. Never-
theless, some normal subjects drinking the high dose of
BTPP had nausea that may have been due to their fasting
overnight and the taste of black tea.
Based on our result and previously published data, we
have shown that BTPP can decrease postprandial glucose
after sucrose intake. The drinks containing BTPP might
inhibit α-amylase, α-glucosidase, and sodium-glucose
transporters activity resulting in block of carbohydrate
absorption causing decreased postprandial blood glucose.
Our findings suggest that ingestion of black tea with food
containing sugar is beneficial in glycemic control and
diabetic prevention.
Conclusion
The consumption of black tea containing BTPP can de-
crease postprandial blood glucose after sucrose intake in
both normal subjects and pre-diabetes subjects, suggest-
ing that black tea may be a promising anti-diabetic agent
for glycemic control.
(A)
(B)
Figure 2. Effect of the black tea consumption on blood insulin levels after sucrose loading in normal and pre-diabetic subjects. (A) In-
cremental blood insulin after sucrose loading in normal subjects. (B) Incremental blood insulin after sucrose loading in pre-diabetic sub-
jects. No statistically significant difference between groups.
64 A Butacnum, R Chongsuwat and A Bumrungpert
ACKNOWLEDGEMENT
The authors thank Assoc. Prof Dr Harold C Furr, Department of
Nutrition, University of Wisconsin, Madison, USA for reading
and editing the final manuscript. This study was funded by Sun-
tory Beverage & Food Limited (Japan).
AUTHOR DISCLOSURES
The authors declare no conflict of interest regarding this paper.
REFERENCES
1. American Diabetes Association. Economic costs of diabetes
in the US in 2002. Diabetes Care. 2003;26:917-32. doi: 10.
2337/diacare.26.3.917.
2. Bonora E, Muggeo M. Postprandial blood glucose as a risk
factor for cardiovascular disease in type II diabetes: the epi-
demiological evidence. Diabetologia. 2001;44:2107-14. doi:
10.1007/s001250100020
3. Wang D, Kurasawa E, Yamaguchi Y, Kubota K, Kobayashi
A. Analysis of glycosidically bound aroma precursors in tea
leaves 2. Changes in glycoside contents and glycosidase ac-
tivities in tea leaves during the black tea manufacturing pro-
cess. J Agric Food Chem. 2001;49:1900-3. doi: 10.1021/
jf001077+.
4. Leung LK, Su Y, Chen R, Zhang Z, Huang Y, Chen ZY.
Theaflavins in black tea and catechins in green tea are equal-
ly effective anti-oxidants. J Nutr. 2001;131:2248 -51.
5. W Luczaj, E Skrzydlewska. Antioxidative properties of
black tea. Prev Med. 2005;40:910-8. doi: 10.1016/j.ypmed.
2004.10.014.
6. Neyestani TR, Shariatzade N, Kalayi A, Gharavi A, Khalaji
N, Dadkhah M, Zowghi T, Haidari H, Shab-bidar S. Regular
daily intake of black tea improves oxidative stress bi-
omarkers and decreases serum c-reactive protein levels in
type 2 diabetic patients. Ann Nutr Metab. 2010;57:40-9. doi:
10.1159/000312666.
7. Maitya S, Ukilb A, Karmakarb S, Dattab D, Chaudhuric T,
Vedasiromonia JR, Ganguly DK, Das PK. Thearubigin, the
major polyphenol of black tea, ameliorates mucosal injury in
trinitrobenzene sulfonic acid-induced colitis. Eur J Pharma-
col. 2003;470:103-12. doi: 10.1016/S0014-2999(03)01760-6.
8. Sanga S, Lamberta JD, Tianc S, Honga J, Houa Z, Ryua JH
et al. Enzymatic synthesis of tea theaflavin derivatives and
their anti-inflammatory and cytotoxic activities. Bioorg Med
Chem. 2004;12:459-67. doi: 10.1016/j.bmc.2003.10.024.
9. Way TD, Lee HH, Kao MC, Lin JK. Black tea polyphenol
theaflavins inhibit aromatase activity and attenuate tamoxi-
fen resistance in HER2/neu-transfected human breast cancer
cells through tyrosine kinase suppression. Eur J Cancer.
2004;40:2165-74. doi: 10.1016/j.ejca.2004.06.018.
10. Krishnan R, Maru GB. Inhibitory effect(s) of polymeric
black tea polyphenol fractions on the formation of [3H]-B (a)
P-derived DNA adducts. J Agric Food Chem. 2004;52:
4261-9. doi: 10.1021/jf049979o.
11. Hodgson JM, Croft KD, Woodman RJ, Puddy IB, Fuchs D,
Draijer R, Lukoshkova E, Head GA. Black tea lowers the
rate of blood pressure variation: a randomized controlled tri-
al. Am J Clin Nutr. 2013;97:943-50. doi: 10.3945/ajcn.112.
051375.
12. Hodgson JM, Woodman RJ, Puddy IB, Mulder T, Fuchs D,
Croft KD. Short-term effects of polyphenol-rich black tea on
blood pressure in men and women. Food Funct. 2013;4:
111-5. doi: 10.1039/c2fo30186e.
13. Kashket S, Paolino VJ. Inhibition of salivary amylase by
water-soluble extracts of tea. Arch Oral Biol. 1988;33:845-6.
doi: 10.1016/0003-9969(88)90110-0.
14. Zhang J, Kashket S. Inhibition of salivary amylase by black
and green teas and their effects on the intraoral hydrolysis of
starch. Caries Res. 1998;32:233-8. doi: 10.1159/000016458.
15. Matsui T, Yoshimoto C, Osajima K, Oki T, Osajima Y. In
vitro survey of alpha- glucosidase inhibitory food compo-
nents. Biosci Biotechnol Biochem. 1996;60: 2019-22. doi:
10.1271/bbb.60.2019.
16. Shimizu M, Kobayashi Y, Suzuki M, Satsu H, Miyamoto Y.
Regulation of intestinal glucose transport by tea catechins.
Biofactors. 2000;13:61-5. doi: 10.1002/biof.5520130111.
17. Zhong L, Furne JK, Levitt MD. An extract of black, green,
and mulberry teas causes malabsorption of carbohydrate but
not of triacylglycerol in healthy volunteers. Am J Clin Nutr.
2006;84:551-5.
18. Bryans JA, Judd PA, Ellis PR. The effect of consuming
instant black tea on postprandial plasma glucose and insulin
concentrations in healthy humans. J Am Coll Nutr. 2007;26:
471-7. doi: 10.1080/07315724.2007.10719638.
19. Adisakwattana S, Lerdsuwankij O, Poputtachai U, Minipun
A, Suparpprom C. Inhibitory activity of cinnamon bark spe-
cies and their combination effect with acarbose against in-
testinal α-glucosidase and pancreatic α-amylase. Plant Foods
Hum Nutr. 2011;66:143-8. doi: 10.1007/s11130-011-0226-4.
20. Beejmohun V, Peytavy-Izard M, Mignon C, Muscente-
Paque D, Deplanque X, Ripoll C, Chapal1 N. Acute effect
of Ceylon cinnamon extract on postprandial glycemia: al-
pha-amylase inhibition, starch tolerance test in rats, and ran-
domized crossover clinical trial in healthy volunteers. BMC
Complement Altern Med. 2014;14:351. doi: 10.1186/1472-
6882-14-351.
... However, some human health investigations have implied that drinking black tea might be an effective adjunct to diabetes. A randomized, double-blind, placebocontrolled crossover study revealed that black tea consumption could decrease postprandial blood glucose compared with a placebo after sucrose intake [10]. In another study of 63,000 people aged 45 to 74 in Singapore, those who drank at least one cup of black tea per day had a 14% lower risk of diabetes than non-tea drinkers [11]. ...
Article
Full-text available
The bioactivity of tea polysaccharides (TPs) has been widely reported, but studies to date have focused on green tea. Some human health investigations have implied that black tea may possess potential antidiabetic effects, but less is known about their potential role and related antidiabetic mechanism. The present study was, therefore, conducted to investigate the chemical properties and antidiabetic activity of TPs from black tea. Monosaccharide composition revealed that Alduronic acid (77.8 mol%) considerably predominated in the fraction. TP conformation analysis indicated that three components in TPs were all typical of high-branching structures. Oral administration of TPs could effectively alleviate fasting blood glucose in type 2 diabetes mellitus (T2D) mice, with the values 23.6 ± 1.42, 19.6 ± 2.25, and 16.4 ± 2.07 mmol/L in the 200, 400, and 800 mg/kg·BW groups, respectively. Among these TPs groups, the 800 mg/kg·BW groups significantly decreased by 37.88% when compared with the T2D+water group (p < 0.05). Further studies demonstrated that TP treatment upregulated the expression of p-Akt/p-PI3K (p < 0.001). Additionally, TP treatment significantly promoted glucose transporter protein 2 (GLUT2) translocation in the liver (p < 0.001). These findings suggest that TPs from black tea protect against T2D by activating PI3K/Akt/GLUT2 signaling and might serve as a novel therapeutic candidate for T2D.
... Among TFs, TF3 exhibits the most potent hypoglycemic effect [53][54][55][56]. Clinical studies have reported that TFs significantly reduce the fasting and postprandial blood glucose level in prediabetics [54,57,58]. Further, a randomized trial has demonstrated that TFs exert a more pronounced hypoglycemic effect in younger individuals compared to older ones [59]. ...
Article
Full-text available
In diabetes mellitus, disordered glucose and lipid metabolisms precipitate diverse complications, including nonalcoholic fatty liver disease, contributing to a rising global mortality rate. Theaflavins (TFs) can improve disorders of glycolipid metabolism in diabetic patients and reduce various types of damage, including glucotoxicity, lipotoxicity, and other associated secondary adverse effects. TFs exert effects to lower blood glucose and lipids levels, partly by regulating digestive enzyme activities, activation of OATP-MCT pathway and increasing secretion of incretins such as GIP. By the Ca2+-CaMKK ꞵ-AMPK and PI3K-AKT pathway, TFs promote glucose utilization and inhibit endogenous glucose production. Along with the regulation of energy metabolism by AMPK-SIRT1 pathway, TFs enhance fatty acids oxidation and reduce de novo lipogenesis. As such, the administration of TFs holds significant promise for both the prevention and amelioration of diabetes mellitus.
... Among the thirty-six eligible studies, ten studies enrolled patients with either T2DM or prediabetes, 13,[27][28][29][30][31][32][33][34]49 seven studies enrolled overweight or obese subjects, [14][15][16]36,42,45,47 three studies enrolled patients with metabolic syndrome or their risk factors, 19,20,50 three studies evaluated patients dyslipidemia, 12,21,35 two studies enrolled patients with hepatic steatosis or non-alcoholic fatty liver disease (NAFLD), 39,41 other studies enrolled patients with CVD or CVD risk factors, 37,40 diabetic nephropathy, 38 and healthy volunteers. 1,22,25,26,43,44,46,48 The primary intervention for metabolic disorders entails dietary and lifestyle modifications. ...
Article
Full-text available
The relationship between the immune system and metabolic diseases is complex and increasingly recognized as critical to understanding conditions like obesity, diabetes, and cardiovascular diseases. Modulation of the immune system in patients with metabolic disorders can offer several potential benefits. While the salutary impact of plant-derived bioactive compounds on metabolic and immune functions is acknowledged, there is a paucity of comprehensive reviews on the multifaceted and synergistic mechanisms through which these effects are mediated. This review elucidates the therapeutic potential of phytochemical formulations in ameliorating metabolic disorders and delineates their mechanistic implications on relevant biomarkers and immune modulation. Our analysis reveals a predominance of plant species, including Boswellia serrata, Cinnamomum cassia, Citrus bergamia, Coffea arabica, Ficus racemosa, Momordica charantia, Morus Alba, and Trigonella foenum-graecum, that have undergone clinical evaluation and have been substantiated to confer both metabolic and immunological benefits. The phytoconstituents contained in these plants exert their effects through a range of mechanisms, such as improving glucose regulation, reducing inflammatory responses, and modulating immune system. As such, these findings hold considerable promise for clinical and therapeutic translation and necessitate further empirical validation through randomized controlled trials and mechanistic elucidations to affirm the safety and efficacy of herbal formulations.
... Ethical considerations. This study was conducted in compliance with ethical principles based on the Helsinki Declaration (final revision, October 2013) and the Ethical Guidelines for Medical and Health Research Involving Human Subjects (Ministry of Education, Culture, Sports, Science and Technology (MEXT); Ministry of Health, Labor and Welfare (MHLW); Ministry of Economy, Trade and Industry (METI) Notification No. 1,2021). This clinical study plan was reviewed and approved by the Institutional Review Board of Chiyoda Paramedical Care Clinic on September 20, 2019 (Approval number 19092004) and registered UMIN-CTR before commencing the study (UMIN Study ID: UMIN000038168). ...
Article
We previously reported that black tea consumption for 12 wk reduced the risk of acute upper respiratory tract inflammation, and improved secretory capacity in individuals with low salivary SIgA levels (Tanaka Y et al. 2021. Jpn Pharmacol Ther 49: 273–288). These results suggested that habitual black tea consumption improves mucosal immunity. Therefore, in this study we evaluated the effect of black tea intake on gut microbiota, which is known to be involved in mucosal immunity, by analyzing the bacterial flora and the short-chain fatty acids (SCFAs) concentration of feces collected during the above clinical study. The clinical design was a randomized, single-blind, parallel-group, placebo-controlled study with 72 healthy Japanese adult males and females, who consumed three cups of black tea (Black Tea Polymerized Polyphenols 76.2 mg per day) or placebo per day for 12 wk. In all subjects intake of black tea significantly increased abundance of Prevotella and decreased fecal acetic acid concentration. Particularly in the subjects with low salivary SIgA levels, the change over time of total bacteria, Prevotella, and butyrate-producing bacteria, which are involved in normalizing immune function, were higher in the black tea group than in the placebo group. In subjects with low abundance of Flavonifractor plautii a butyrate-producing bacteria, black tea consumption significantly increased salivary SIgA concentration and the absolute number of Flavonifractor plautii. In conclusion, our results suggest that improvement of mucosal immunity via an increase in butyrate-producing bacteria in the gut may partly contribute to the suppressive effect of black tea consumption on acute upper respiratory tract inflammation observed in our previous report.
... This pilot was conducted with 7 people testing the infusion with either 1 g or 2 g, where 5 out of 7 preferred the first option. The placebo tea was prepared using a food coloring, E150a, in the same way as previous authors [17]. The test products were offered as part of a standardized, carbohydrate-rich, mixed breakfast meal containing 110 g of wheat bread and 50 g of peach jam. ...
Article
Full-text available
This study investigates the effect of olive leaf tea (OLT) on postprandial glycemia in healthy volunteers when ingested with a high-carbohydrate meal, compared with a placebo tea (CON). Healthy adults participated in a double-blind, randomized, placebo-controlled, and cross-over design trial receiving a high-rich carbohydrate meal with either 250 mL of OLT or CON at two different times after a washout period. The sequence order was randomized at a ratio of 1:1. Capillary blood glucose was measured in a 2 h period after ingestion. Eighteen participants were initially randomized. Of these, thirteen completed the trial and were analyzed. The consumption of OLT resulted in a delay in peak time (48.5 ± 4.2 min vs. 35.7 ± 4.0 min, p = 0.03) and a significant increase in glucose area under the curve compared to placebo (14,502.7 ± 640.8 vs. 13,633.3 ± 869.4 mg/dL.min, p = 0.03). Results are depicted as mean ± SEM. The OLT and CON palatability were generally well accepted. No adverse effects were reported. OLT did not ameliorate a glycemic curve induced by carbohydrate-rich meal ingestion, suggesting that at least when ingested acutely in a single meal, OLT does not have antihyperglycemic effects. Future studies should account for chronic consumption providing a better understanding of glycemic regulation over time.
... Likewise, we also found that Se-BT showed a better improvement effect than BT. Previous research [14] show a signi cant improvement in OGTT in diabetic patients after ingestion of sucrose drinks containing BT polyphenols, but no signi cant difference in insulin tolerance. It may not be the tea polyphenols but other components that improve IR. ...
Preprint
Full-text available
Black tea is one of the six major tea categories and has a variety of bioactivities. However, little is known about its comprehensive evaluation of hypoglycemic effects and potential mechanisms. In this study, we investigated the in vivo hypoglycemic activity and potential mechanism for aqueous extracts of ordinary black tea (BT) and selenium-enriched black tea (Se-BT) by using an established high-fat diet together with streptozotocin-induced hyperglycemic mouse model. Additionally, we also explored their α-glucosidase inhibition activity. The results show that both BT and Se-BT had a favorable glycosidase inhibitory activity. Moreover, the intervention of BT and Se-BT could regulate the mRNA expression and the level of serum parameters related to glucose and lipid metabolisms. Accordingly, they could activate the phosphoinositide-3-kinase/protein kinase B (PI3K/Akt) signaling pathway and alleviate insulin resistance (IR) and hyperglycemia. Moreover, supplementation of BT and Se-BT increased the richness and diversity of intestinal flora and altered the abundance of beneficial and harmful bacteria. Both BT and Se-BT could regulate glucose metabolism, alleviate tissue damage, and restore intestinal flora dysbiosis, suggesting that they could be used as a natural functional food for preventing hyperglycemia.
Article
Full-text available
Purpose The use of nutrients and food supplements is increasing worldwide. Nutrients and food supplements frequently used in the surgical period may cause complications and side effects. This study was conducted to determine the level of knowledge about sixty-one nutrients and food supplements among doctors and nurses working in surgical clinics. Design A multicentre descriptive, quantitative, cross-sectional study. Methods The study was conducted between 15 February and 31 May 2022 with a total of 410 participants, including 143 doctors and 267 nurses, working in the surgical clinics of 8 hospitals, including public, university and private hospitals, within the borders of one province in Turkey. Data were collected face-to-face using a questionnaire developed by the researchers, which included descriptive characteristics of the doctors and nurses and questions about sixty-one nutrients and food supplements. Results The median overall success score of the doctors and nurses participating in the study regarding the use of nutrients and food supplements was 3.20 out of 100 points, the median success score of complications and side effects of nutrients and food supplements in the surgical period was 7.06 out of 33 points, the median success score for discontinuation of nutrients and food supplements prior to surgery was 0.21 out of 16 points, and the median success score for drug interactions of nutrients and food supplements was 1.70 out of 51 points. In addition, it was found that the overall success scores of doctors and nurses regarding nutrients and food supplements increased statistically significantly with increasing age and working years. The total success score of doctors and nurses who received training in nutrients and food supplements was statistically significantly higher than that of doctors and nurses who did not receive training. Conclusion In conclusion, it was found that the level of knowledge of nutrients and food supplements among doctors and nurses working in surgical clinics was less than half or even close to zero. Therefore, it is recommended that training on nutrients and food supplements should be included in the undergraduate and postgraduate education of doctors and nurses in order to prevent complications, side effects, drug interactions and patient safety related to the use of nutrients and food supplements in the surgical period.
Article
Full-text available
Black tea is one of the six major tea categories and has a variety of bioactivities. However, little is known about its comprehensive evaluation of hypoglycemic effects and potential mechanisms. In this study, we investigated the in vivo hypoglycemic activity and potential mechanism for aqueous extracts of ordinary black tea (BT) and selenium-enriched black tea (Se-BT) by using an established high-fat diet together with streptozotocin (STZ)-induced hyperglycemic mouse model. Additionally, we also explored their α-glucosidase inhibition activity. The results show that both BT and Se-BT had a favorable glycosidase inhibitory activity. Moreover, the intervention of BT and Se-BT could regulate the mRNA expression and the level of serum parameters related to glucose and lipid metabolisms. Accordingly, they could activate the phosphoinositide-3-kinase/protein kinase B (PI3K/Akt) signaling pathway and alleviate insulin resistance (IR) and hyperglycemia. Moreover, supplementation of BT and Se-BT increased the richness and diversity of intestinal flora and altered the abundance of beneficial and harmful bacteria. Both BT and Se-BT could regulate glucose metabolism, alleviate tissue damage, and restore intestinal flora dysbiosis, suggesting that they could be used as a natural functional food for preventing hyperglycemia.
Article
Black tea, rich in various and complex polyphenols, is one of the most popular beverages in the world due to its pleasant aroma and health benefits, such as alleviate hyperglycemia and antioxidant. The extensive investigation on the chemical constituents of Yunnan black tea 'Jin-Ya', produced from the leaf buds of Camellia sinensis var. assamica, led to the isolation and identification of 16 flavonoids including three new flavan-3-ols, namely theaflavoids A-C (1–3). Most of the isolates displayed obvious inhibitory activity on α-glucosidase with IC50 values ranging from 1.11 to 24.7 μM. Notably, the new theaflavoids 1–3 showed much stronger inhibitory activity (IC50 = 1.34, 1.11, and 4.57 μM, respectively) than those of the positive controls (acarbose and quercetin, IC50 = 228 and 9.38 μM, respectively). In addition, the isolated flavonol glycosides 5–16 were evaluated for their antioxidant activities by DPPH and ABTS ⁺ radical scavenging assays. Those with galloyl group in molecular exhibited comparable free radical scavenging activities to the positive controls (ascorbic acid and Trolox), while most of the flavonol glycosides showed only moderate activities. The results indicated that Yunnan black tea 'Jin-Ya' is an ideal drink with hypoglycemic and antioxidant property, and is worthy of regular consumption.
Article
Background Flavonoid intake is significantly associated with risk reduction and/or improvement in impaired glucose tolerance and diabetes. Foods containing encapsulated flavonoids are being designed, but the particles must remain stable in the food matrix during processing, storage, and utilization, as well as being bioavailable after ingestion. Control of these variables would enable the food industry to design functional foods targeted to the diabetic population. Scope and approach This article reviews recent advances in the encapsulation of flavonoids, with a focus on the design of delivery systems that can control the stability and bioavailability of flavonoids in foods, thereby increasing their ability to reduce the risk or treat diabetes. Key findings and conclusions: Although flavonoids represent a good option for the development of diabetic-friendly food products, it is important to emphasize that their effectiveness is linked to the way these compounds are delivered, released, absorbed, and metabolized. Consequently, the choice of appropriate encapsulation materials and methods are crucial, as they determine the flavonoid retention capacity, particle/food matrix interactions, and the release profile.
Article
Full-text available
Background: Measures of blood pressure variation have been associated with cardiovascular disease and related outcomes. The regular consumption of black tea can lower blood pressure, but its effects on blood pressure variation have yet to be investigated. Objective: We aimed to assess the effects of black tea consumption on the rate of ambulatory blood pressure variation. Design: Men and women (n = 111) with systolic blood pressure between 115 and 150 mm Hg at screening were recruited in a randomized, controlled, double-blind, 6-mo parallel-designed trial designed primarily to assess effects on blood pressure. Participants consumed 3 cups/d of either powdered black tea solids (tea) or a flavonoid-free caffeine-matched beverage (control). The 24-h ambulatory blood pressure level and rate of measurement-to-measurement blood pressure variation were assessed at baseline, day 1, and 3 and 6 mo. Results: Across the 3 time points, tea, compared with the control, resulted in lower rates of systolic (P = 0.0045) and diastolic (P = 0.016) blood pressure variation by ~10% during nighttime (2200-0600). These effects, which were immediate at day 1 and sustained over 6 mo, were independent of the level of blood pressure and heart rate. The rate of blood pressure variation was not significantly altered during daytime (0800-2000). Conclusions: These findings indicate that a component of black tea solids, other than caffeine, can influence the rate of blood pressure variation during nighttime. Thus, small dietary changes have the potential to significantly influence the rate of blood pressure variation. This trial was registered at the Australian New Zealand Clinical Trials Registry as ACTR12607000543482.
Article
Full-text available
This study was undertaken to evaluate the possible effects of different daily doses of black tea intake on certain oxidative stress, inflammatory and metabolic biomarkers in patients with type 2 diabetes mellitus (T2DM). Forty-six patients with known T2DM were randomly assigned either to the test (n = 23, 57.0 +/- 7.9 years) or the control (n = 23, 55.4 +/- 8.3 years) group. Following a one-week 'run-in' period, the test group received 150, 300, 450 and 600 ml of black tea extract (BTE) during the weeks 1, 2, 3 and 4, respectively. The control group received 150 ml BTE a day throughout the intervention period. Dietary, anthropometric and biochemical assessments were performed at the end of each week. Serum total antioxidant capacity was enhanced similarly in both test and control groups. However, daily intake of 2 cups of BTE by the test group showed a suppressing effect on serum malondialdehyde. Serum C-reactive protein significantly decreased and glutathione levels increased following the intake of 4 cups (600 ml) of BTE a day. Regular intake of BTE had anti-oxidative and anti-inflammatory effects in patients with T2DM. These findings may, to some extent, explain the mechanisms underlying the protective effects of drinking tea against cardiovascular disease.
Article
Full-text available
That cardiovascular disease occurs more frequently in patients with Type II (non-insulin-dependent) diabetes mellitus has been recognized for a long time. However, the extent to which hyperglycaemia contributes to atherosclerosis and cardiovascular disease is still not clear. Epidemiological studies published in recent years suggest that postprandial blood glucose might be an independent risk factor of cardiovascular disease. The main results of these studies, which are reviewed in this article, are that subjects from the general population with mild to moderate hyperglycaemia, following oral glucose load, but not in the fasting state, showed an increased cardiovascular risk. Furthermore, the post-challenge as well as postprandial glucose concentrations of subjects with Type II diabetes were found to be directly associated to incident cardiovascular disease independently of fasting glucose. Also, the correction of fasting hyperglycaemia or HbA1 c or both, disregarding the specific correction of postprandial hyperglycaemia was not found to significantly reduce the incidence of cardiovascular disease in patients with Type II diabetes. Finally, the strict control of both preprandial and postprandial hyperglycaemia yielded a substantial reduction of cardiovascular disease in Type II diabetes. Trials specifically designed to address this issue are needed to determine whether postprandial hyperglycaemia plays an independent and causative role in cardiovascular disease in patients with Type II diabetes.
Article
Inhibition of α-glucosidase and pancreatic α-amylase is one of the therapeutic approaches for delaying carbohydrate digestion, resulting in reduced postprandial glucose. The aim of this study was to evaluate the phytochemical analysis and the inhibitory effect of various cinnamon bark species against intestinal α-glucosidase and pancreatic α-amylase. The results showed that the content of total phenolic, flavonoid, and condensed tannin ranged from 0.17 to 0.21 g gallic acid equivalent/g extract, from 48.85 to 65.52 mg quercetin equivalent/g extract, and from 0.12 to 0.15 g catechin equivalent/g extract, respectively. The HPLC fingerprints of each cinnamon species were established. Among cinnamon species, Thai cinnamon extract was the most potent inhibitor against the intestinal maltase with the IC(50) values of 0.58 ± 0.01 mg/ml. The findings also showed that Ceylon cinnamon was the most effective intestinal sucrase and pancreatic α-amylase inhibitor with the IC(50) values of 0.42 ± 0.02 and 1.23 ± 0.02 mg/ml, respectively. In addition, cinnamon extracts produced additive inhibition against intestinal α-glucosidase and pancreatic α-amylase when combined with acarbose. These results suggest that cinnamon bark extracts may be potentially useful for the control of postprandial glucose in diabetic patients through inhibition of intestinal α-glucosidase and pancreatic α-amylase.
Article
A number of studies indicate that tea extracts are effective in reducing caries in humans as well as in animals. The present experiments demonstrated the inhibition of salivary amylase activity by extracts of a commercial tea. Inhibition was dependent on the tea:saliva ratio so that, in vivo, conditions may permit optimal inhibition during and immediately after tea ingestion. The effect on salivary amylase may contribute significantly to reducing the cariogenicity of starch-containing foods.
Article
A survey of food components with alpha-glucosidase (AGH) inhibitory activity was conducted to identify a prophylactic effect for diabetes in food. Sardine muscle hydrolyzed by alkaline protease showed potent activity (IC50 = 48.7 mg/ml) as well as green and oolong teas (IC50 = 11.1 and 11.3 mg/ml, respectively). Furthermore, hydrolyzates prepared by various proteases gave differing AGH inhibitory activity. DEAE-Sephadex chromatography of the alkaline protease hydrolyzate eluted potent AGH inhibitors (IC50 = 15.6 mg/ml) with a 50 mM phosphate buffer (pH 7.0) containing 0.3 M NaCl, and their subsequent separation by HPLC in an ODS column showed that there were some inhibitors possessing primary amino groups. This indicates that they would have been high anionic and peptidic compounds.
Article
Tea decoctions prepared from a number of black and green teas inhibited amylase in human saliva. Black teas gave higher levels of inhibition than green teas, and removal of tea tannins with gelatin led to the loss of inhibitory activity from all decoctions. Streptococcal amylase was similarly inhibited by tea decoctions. Fluoride was without effect on amylase. Since salivary amylase hydrolyzes food starch to low molecular weight fermentable carbohydrates, experiments were carried out to determine whether tea decoctions would interfere with the release of maltose in food particles that became entrapped on the dentition. Subjects consumed salted crackers and rinsed subsequently for 30 s with black or green tea decoctions, or water. Maltose release was reduced by up to about 70% after rinsing with the teas. Black tea decoction was significantly more effective than green tea, in agreement with the in vitro data. The observations supported the hypothesis that tea consumption can be effective in reducing the cariogenic potential of starch-containing foods such as crackers and cakes. Tea may reduce the tendency for these foods to serve as slow-release sources of fermentable carbohydrate.
Article
Intestinal glucose uptake is mainly performed by its specific transporters, such as SGLT 1, GLUT 2 and 5 expressed in the intestinal epithelial cells. By using human intestinal epithelial Caco-2 cells we observed that intestinal glucose uptake was markedly inhibited by tea extracts. While several substances in green tea seem to be involved in this inhibition, catechins play the major role and epicatechin gallate (ECg) showed the highest inhibitory activity. Since our Caco-2 cells did not express enough amount of SGLT 1, the most abundant intestinal glucose transporter, the effect of ECg on SGLT 1 was evaluated by using brush border membrane vesicles obtained from the rabbit small intestine. ECg inhibited SGLT 1 in a competitive manner, although ECg itself was not transported via the glucose transporters. These results suggest that tea catechins could play a role in controlling the dietary glucose uptake at the intestinal tract and possibly contribute to blood glucose homeostasis.
Article
Glycosides are known to be precursors of the alcoholic aroma compounds of black tea. They are hydrolyzed by endogenous glycosidases during the manufacturing process. Changes in the amounts of these glycosides during the manufacturing process were investigated by using a capillary gas chromatographic--mass spectrometric analysis after trifluoroacetyl derivatization of the tea glycosidic fractions. Primeverosides were 3-fold more abundant than glucosides in fresh leaves, but they decreased greatly during the manufacturing process, especially during the stage of rolling. After the final stage of fermentation, primeverosides had almost disappeared, whereas glucosides were substantially unchanged. These results show that hydrolysis of the glycosides mainly occurred during the stage of rolling and confirm that primeverosides are the main black tea aroma precursors. This was also supported by the changes in the glycosidase activities in tea leaves. The glycosidase activities remained at a high level during withering but decreased drastically after rolling.
Article
Green tea catechins, including (-)-epicatechin (EC), (-)-epicatechin gallate (ECG), (-)-epigallocatechin (EGC) and (-)-epigallocatechin gallate (EGCG), are oxidized and dimerized during the manufacture of black tea and oolong tea to form orange-red pigments, theaflavins (TF), a mixture of theaflavin (TF1), theaflavin-3-gallate (TF2A), theaflavin-3'-gallate (TF2B) and theaflavin-3,3'-digallate (TF3). The present study was designed to compare the antioxidant activities of individual TF with that of each catechin using human LDL oxidation as a model. All catechins and TF tested inhibited Cu(+2)-mediated LDL oxidation. Analysis of the thiobarbituric acid-reactive substances (TBARS) and conjugated dienes produced during LDL oxidation revealed that the antioxidant activity was in the order: TF3 > ECG > EGCG > or = TF2B > or = TF2A > TF1 > or = EC > EGC. Four TF derivatives also demonstrated a dose-dependent antioxidant activity in Cu(+2)-mediated LDL oxidation at concentrations of 5-40 micromol/L. These results demonstrate that the TF present in black tea possess at least the same antioxidant potency as catechins present in green tea, and that the conversion of catechins to TF during fermentation in making black tea does not alter significantly their free radical-scavenging activity.